Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor

Children's Oncology Group (COG)


Clinical Trial

Offered by: Nemours
Locations: Delaware Valley, Jacksonville, FL, Orlando, FL, Pensacola, FL

What is the trial about?

To find out if some children with a higher risk of having their tumor return (Stage I or II Wilms tumor with the LOH change) will benefit from the addition of doxorubicin to the current standard treatment regimen.

Who can participate?

Children with a favorable histology (Wilms tumor that has some risk of returning after treatment).

What is involved?

Length of study is 25 weeks. Standard cancer care treatment.

Contact Nemours Clinical Trials

Trial Name: Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor

COG#: AREN0532

Contact Information

(800) 354-5690
clinicaltrials@nemours.org